Koios Beverage (CSE:KBEV, OTC:SNOVF) (the “Company” or “Koios”) is pleased to announce the Company has entered into an agreement (the “Agreement”) for a draw-down equity facility of up to $28,000,000. The Agreement provides for equity private placement offerings (each, an “Offering”), to be conducted between the Company and Alumina Partners (Ontario) Ltd. (“Alumina Partners”), a subsidiary of Alumina Partners LLC, a New York based private equity firm that has made significant investments in the cannabis sector, in draw-down amounts of up to $2,000,000.

Pursuant to the terms of the Agreement, Alumina Partners committed to purchasing up to $28,000,000 worth of units of the Company (each, a “Unit”), consisting of one common share (each, a “Share”) and one half of one common share purchase warrant (each whole warrant, a “Warrant”), with each Unit being purchased at a discount of between 15 to 20% of the then current market price of the Shares, or such lesser discount as dictated by Section 2.1 of Policy 6 of the Canadian Securities Exchange or as mutually agreed by the parties, with each Offering occurring at the sole option of the Company, throughout the 24 month term of the Agreement. The exercise price of the Warrants will be at a 50 per cent premium over the then current market price of the Shares. Each whole Warrant will entitle the holder to purchase one additional share for a period of 24 months from the closing of the applicable Offering. Closing of each Offering is subject to a number of conditions, including receipt of any necessary corporate and regulatory approvals.


The equity facility has been structured to best suit the Company’s rapid growth strategies while maintaining shareholder value. Each draw-down will be drawn upon at the sole discretion of Koios, allowing for the flexibility to access funds only when necessary. This strategy allows Koios to protect shareholder value while growing consumer awareness and meeting production demands for new and existing territories.

“In our minds, Alumina offers the ideal type of financing for a younger company like ours that faces rapid expansion, but also does not want to dilute their shareholders by taking on too much equity investment at lower valuations,” explained Koios CEO Chris Miller. This Agreement will allow us to comfortably fuel our expansion and help the Company execute its transition into profitable growth.”

“The most rapidly expanding and evolving markets – along with the highest gross margins – in the regulated cannabis space are presently in cannabinoid beverages,” said Adi Nahmani, Managing Member of Alumina Partners LLC. “We are pleased to stand behind Koios as they work to extend their commanding lead in this market and move to aggressively add new markets to their growing portfolio.”

All securities issued in connection with an Offering will be subject to a statutory hold period of four months and one day from the date of issuance in accordance with applicable securities legislation.

None of the securities issued in an Offering will be registered under the United States Securities Act of 1933, as amended (the “1933 Act”), and none of them may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act. This news release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of the securities in any state where such offer, solicitation, or sale would be unlawful.

On behalf of the Board of Directors of the Company.

KOIOS BEVERAGE CORP.

“Chris Miller”
Chris Miller, CEO and Director

About Koios Beverage Corp.

The Company is an emerging functional beverage company which has an available distribution network of more than 2,000 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, Western Functional Beverages, KeHE and Wishing-U-Well. Koios is also the sole owner of Cannavated Beverage Corp., a subsidiary that develops beverage products and formulas for the growing cannabis market. Through its agreement with Keef Brands, the largest producer of cannabis beverages in North America, Cannavated enjoys distribution throughout the state of Colorado and is preparing for distribution in additional U.S. states where cannabis use is legal.

Forward-Looking Statements

This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements in this news release include statements regarding (i) the proceeds to be raised pursuant to the equity facility; (ii) resale restrictions relating to the securities to be issued; (iii) the equity facility fueling the Company’s expansion and enabling the Company to grow profitably; and (iv) the Company’s strategy and business plan. The forward-looking statements reflect management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements including: (i) adverse market conditions; (ii) the inability of the Company to complete any Offering at all or on the terms announced; or (iii) the Company not receiving all necessary regulatory approvals. Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty. Factors that could cause actual results or events to differ materially from current expectations include general market conditions and other factors beyond the control of the Company. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.

For further information: Paula Arab, Media and Investor Relations Strategist, paula.arab@koiosbeveragecorp.com, 403-889-9128

Click here to connect with Koios Beverage (CSE:KBEV, OTC:SNOVF) for an Investor Presentation.

Source: www.newswire.ca

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less